MTOR and cardiac hypertrophy: Short-term Akt activation improves contractile function in the failing hearts independent of hypertrophy; however, chronic Akt activation induces cardiac hypertrophy by activating mammalian target of rapamycin (mTOR) in transgenic mice with constitutively active Akt [30–32].